BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boda-Heggemann J, Attenberger U, Budjan J, Jahnke A, Jahnke L, Vogel L, Simeonova-Chergou AO, Herskind C, Wenz F, Lohr F. MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching. Strahlenther Onkol 2016;192:641-8. [PMID: 27393400 DOI: 10.1007/s00066-016-1013-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kuznetsova S, Grendarova P, Sinha R, Ploquin N, Thind K. Auto-delineation framework for the focal liver reaction observed in post Stereotactic Body Radiation Therapy (SBRT) Primovist MRI scans. Med Dosim 2021:S0958-3947(21)00058-3. [PMID: 34376315 DOI: 10.1016/j.meddos.2021.06.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kuznetsova S, Sinha R, Thind K, Ploquin N. Direct visualization and correlation of liver stereotactic body radiation therapy treatment delivery accuracy with interfractional motion. J Appl Clin Med Phys 2021;22:129-38. [PMID: 34240556 DOI: 10.1002/acm2.13333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Walter F, Nierer L, Rottler M, Duque AS, Weingandt H, Well J, Shpani R, Landry G, Seidensticker M, Streitparth F, Ricke J, Belka C, Corradini S. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma. Radiat Oncol 2021;16:86. [PMID: 33957941 DOI: 10.1186/s13014-021-01812-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Stera S, Miebach G, Buergy D, Dreher C, Lohr F, Wurster S, Rödel C, Marcella S, Krug D, Frank A G, Ehmann M, Fleckenstein J, Blanck O, Boda-Heggemann J. Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort. Radiother Oncol 2021;158:230-6. [PMID: 33667585 DOI: 10.1016/j.radonc.2021.02.036] [Reference Citation Analysis]
5 Dreher C, Linde P, Boda-Heggemann J, Baessler B. Radiomics for liver tumours. Strahlenther Onkol 2020;196:888-99. [PMID: 32296901 DOI: 10.1007/s00066-020-01615-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Semrau S, Agaimy A, Pavel M, Lubgan D, Schmidt D, Cavallaro A, Golcher H, Grützmann R, Fietkau R. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report. J Med Case Rep 2019;13:82. [PMID: 30902067 DOI: 10.1186/s13256-019-1995-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
7 Boda-Heggemann J, Jahnke A, Chan MKH, Ernst F, Ghaderi AL, Attenberger U, Hunold P, Schäfer JP, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O. In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations. Radiother Oncol 2019;134:158-65. [PMID: 31005210 DOI: 10.1016/j.radonc.2019.01.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
8 Chen Y, Grassberger C, Li J, Hong TS, Paganetti H. Impact of potentially variable RBE in liver proton therapy. Phys Med Biol 2018;63:195001. [PMID: 30183674 DOI: 10.1088/1361-6560/aadf24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Boda-Heggemann J, Jahnke A, Chan MKH, Ghaderi Ardekani LS, Hunold P, Schäfer JP, Huttenlocher S, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O. Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT. Strahlenther Onkol 2018;194:414-24. [PMID: 29404626 DOI: 10.1007/s00066-018-1271-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]